Canada· CA-DIN-02527693
ORLADEYO
A berotralstat product containing berotralstat (berotralstat hydrochloride), registered in Canada by BIOCRYST PHARMACEUTICALS INC. The same ATC class is registered in 17 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Berotralstat is registered in 17 of 19 countries.
Countries holding a registration under ATC B06AC06 (berotralstat), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 11 of them publish a price we can compare per daily dose
Berotralstat · ATC B06AC06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of berotralstat costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Berotralstat · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$576.89
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- BEROTRALSTAT (BEROTRALSTAT HYDROCHLORIDE)
- Manufacturer
- BIOCRYST PHARMACEUTICALS INC
- Country
- Canada (CA)
- ATC code
- B06AC06
- ATC class
- Berotralstat
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
209 interactions on record for berotralstat.
Graded by severity as the source publishes them — 66 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Berotralstat · interactions on record
209 records
- 66 severe
- 132 moderate
- 11 minor
Most severe, free to view
- RolapitantA04AD14severe
- NaloxegolA06AH03severe
- FidaxomicinA07AA12severe
- EliglustatA16AX10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Berotralstat in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaORLADEYOBIOCRYST IRELAND LIMITED, Dublin
- United StatesOrladeyoBioCryst Pharmaceuticals, Inc.
- SpainORLADEYO 150 MG CAPSULAS DURASBiocryst Ireland Limited
- FinlandOrladeyoBioCryst Ireland Limited
- FranceORLADEYO 150 mg, géluleBIOCRYST IRELAND LIMITED (IRLANDE)
- BelgiumOrladeyo 150 mgBiocryst Ireland
- IcelandOrladeyoBioCryst Ireland Limited
- NetherlandsOrladeyo 150 mg, harde capsuleBioCryst Ireland Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Orladeyo
- Liechtenstein · Orladeyo
- Norway · Orladeyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7fdbf283-d90a-468f-8cee-1337a5c0604c GET /v1/drugs/7fdbf283-d90a-468f-8cee-1337a5c0604c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02527693",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "B06AC06",
"schedule": [
"Prescription"
],
"drug_code": "101674",
"strengths": [
"150 MG"
],
"ahfs_class": null,
"substances": [
"BEROTRALSTAT (BEROTRALSTAT HYDROCHLORIDE)"
],
"product_categorization": null
}See everything about berotralstat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.